| 期刊論文1. | Hogan, T. P.,、Awad, A. G.,、Eastwood, R.(1983)。A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity。Psychological Medicine,13,177-183。 | 2. | Boden, R.、Brant, L.、Kieler, H.、Andersen, M.、Reutfors, J.(2011)。Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder。Schizophr Res,113,36-41。 | 3. | 陳夏蓮、蔡仁貞(20120200)。症狀經驗、病因解釋與治療遵從行為--以高血壓病人為例。護理雜誌,59(1),5-10。 延伸查詢 | 4. | Abdel-Baki, A、Ouellet-Plamondon, C.、Malla, A.(2012)。Pharmacotherapy challenges in patients with first-episode psychosis。Journal of Affective Disorders,138,3-14。 | 5. | Ascher-Svanum, H、Nyhuis, A. W、Stauffer, V.、Kinon, B. J.、Faries, D. E、Phillips, G. A.、Naber, D.(2010)。Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives。Current Medical Research and Opinion,26(10),2403-2410。 | 6. | Beck, E. M.、Cavelti, M.、Wirtz, M、Kossowsky, J、Vauth, R.(2011)。How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia ? A cluster-analytical approach。Psychiatry Research,187(1-2),55-61。 | 7. | Bosworth, H. B.、Granger, B. B.、Mendys, P.、Brindis, R.、Burkholder,R.、Czajkowski, S. M、Granger, C. B(2011)。Medication adherence: A call for action。American Heart Journal,162(3),412-424。 | 8. | Bressington, D.、Mui, J.、Gray, R.(2013)。Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: A cross sectional study。International Journal of Mental Health Nursing,22(1),35-46。 | 9. | Chang, C. M.、Wu, K. Y.、Liang, H. Y.、Wu, E. C. H.、Chen, C.Y.、Wu, C. S、Tsai, H. J.(2012)。Adherence patterns with first- versus second-generation antipsychotics for newly diagnosed schizophrenia in Taiwan。Psychiatric Services,63(5),504-507。 | 10. | Charrier, N.、Chevreul, K.、Durand-Zaleski, I.(2013)。The cost of schizophrenia: A literature review。L'Encéphale,39(1),S49-S56。 | 11. | DiMatteo, M. R.(2004)。Variations in patientsâ adherence to medical recommendations: A quantitative review of 50 years of research。Medical Care,42(3),200-209。 | 12. | Dolder, C. R.、Lacro, J. P、Leckband, S.、Jeste, D. V.(2003)。Interventions to improve antipsychotic medication adherence:Review of recent literature。Journal of Clinical Psychopharmacology,23(4),389-399。 | 13. | Gaebel, W.、Riesbeck, M.、von Wilmsdorff, M.、Burns, T.、Derks, E. M.、Kahn, R. S、EUFEST Study Group(2010)。Drug attitude as predictor for effectiveness in firstepisode schizophrenia: Results of an open randomized trial(EUFEST)。European Neuropsychopharmacology,20(5),310-316。 | 14. | Gilmer, T. P.、Dolder, C. R.、Lacro, J. P.、Folsom, D. P.、Lindamer,L.、Garcia, P、Jeste, D. V.(2004)。Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia。American Journal of Psychiatry,161(4),692-699。 | 15. | Glick, I. D.、Stekoll, A.、H.Hays, S(2011)。The role of the family and improvement in treatment maintenance, adherence, and outcome for schizophrenia。Journal of Clinical Psychopharmacology,31(1),82-85。 | 16. | Hardeman, S. M.、Harding, R. K.(2010)。Simplifying adherence in schizophrenia。Psychiatric Services,61(4),405-408。 | 17. | Haynes, R. B.、Sackett, D. L.、Gibson, E. S.、Taylor, D. W.、Hackett, B. C.、Roberts, R. S、Johnson, A. L.(1976)。Improvement of medication compliance in uncontrolled hypertension。The Lancet,307(7972),1265-1268。 | 18. | Kao, Y. C、Liu, Y. P.(2010)。Compliance and schizophrenia:The predictive potential of insight into illness, symptoms, and side effects。Comprehensive Psychiatry,51(6),557-565。 | 19. | Kikkert, M. J、Barbui, C.、Koeter, M. W、David, A. S.、Leese,M、Tansella, M.、Schene, A. H.(2008)。Assessment of medication adherence in patients with schizophrenia: The Achilles heel of adherence research。The Jounal Nervous and Mental Disease,196(4),274-281。 | 20. | Kopelowicz, A.、Zarate, R.、Wallace, C. J.、Liberman, R. P.、Lopez,S. R、Mintz, J.(2012)。The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia。Archives of General Psychiatry,69(3),265(273)。 | 21. | Lan, C. M.、Shiau, S. J、Lin, L. C.(2003)。Knowledge, Knowledge beliefs,attitudes, and drug compliance in schizophrenic patients。Tzu Chi Medical Journal,15(6),369-375。 | 22. | Leucht, S.、Tardy, M.、Komossa, K.、Heres, S.、Kissling, W.、Salanti, G.、Davis, J. M.(2012)。Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis。The Lancet,379(9831),2063-2071。 | 23. | Masand, P. S.、Roca, M.、Turner, M. S、Kane, J. M.(2009)。Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: A review。The Primary Care Companion to the Journal of Clinical Psychiatry,11(4),147-154。 | 24. | Misdrahi, D.、Petit, M、Blanc, O.、Bayle, F.、Llorca, P. M(2012)。The influence of therapeutic alliance and insight on medication adherence in schizophrenia。Nordic Journal of Psychiatry,66(1),49-54。 | 25. | Montes, J. M、Medina, E.、Gomez-Beneyto, M、Maurino, J(2012)。A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia。Psychiatry Research,200(2-3),89-95。 | 26. | Mutschler, J.、von Zitzewitz, F、Rössler, W.、Grosshans, M.(2012)。Application of electronic diaries in patients with schizophrenia and bipolar disorders。Psychiatria Danubina,24(2),206-210。 | 27. | Quirk, A.、Chaplin, R.、Hamilton, S.、Lelliott, P.、Seale, C.(2013)。Communication about adherence to long-term antipsychotic prescribing: An observational study of psychiatric practice。Social Psychiatry and Psychiatric Epidemiology,,48(4),639-647。 | 28. | Remington, G.、Kwon, J.、Collins, A、Laporte, D.、Mann, S、Christensen, B.(2007)。The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia。Schizophrenia Research,90(1-3),229-237。 | 29. | Shelton, P. S、Mozingo, D. B.、Avissar, P. S.、Karg, M.、Charboneau,A. L、Rich, W(2012)。Measuring adherence in a community-based elderly population。The Consultant Pharmacist,27(11),771-781。 | 30. | Tiihonen, J.、Haukka, J、Taylor, M.、Haddad, P. M、Patel, M.X、Korhonen, P.(2011)。A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia。American Journal of Psychiatry,168(6),603-609。 | 31. | Tsai, J. K.、Lin, W. K、Lung, F. W.(2011)。Social interaction and drug attitude effectiveness in patients with schizophrenia。Psychiatric Quarterly,82(4),343-351。 | 32. | Tzeng, J. I.、Chang, C. C.、Chang, H. J、Lin, C. C(2008)。Assessing analgesic regimen adherence with the morisky medication adherence measure for Taiwanese patients with cancer pain。Journal of Pain and Symptom Management,36(2),157-166。 | 33. | Velligan, D. I.、Weiden, P. J.、Sajatovic, M.、Scott, J.、Carpenter, D.、Ross, R.、Docherty, J. P.(2010)。Assessment of adherence problems in patients with serious and persistent mental illness: Recommendations from the expert consensus guidelines。Journal of Psychiatric Practice,16(1),34-45。 | 34. | Yang, J.、Ko, Y. H.、Paik, J. W、Lee, M. S.、Han, C.、Joe, S. H.、Kim, S. H.(2012)。Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia。Schizophrenia Research,134(2/3),226-231。 | 35. | Mueser, K. T.、McGurk, S. R.(2004)。Schizophrenia。The Lancet,363(9426),2063-2072。 | 36. | Morisky, D. E.、Green, L. W.、Levine, D. M.(1986)。Concurrent and predictive validity of a self-reported measure of medication adherence。Medical Care,24(1),67-74。 | 37. | Thompson, K.、Kulkarni, J.、Sergejew, A. A.(2000)。Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses。Schizophrenia Research,42(3),241-247。 | 學位論文1. | 林美吟(2008)。預測精神分裂症病患藥物遵從性的影響因素分析(碩士論文)。高雄醫學大學。 延伸查詢 | 2. | 陳美蘭(2010)。社區精神分裂病人病識感、服藥遵從行為及其影響因素之探討(碩士論文)。美和技術學院。 延伸查詢 | 其他1. | World Health Organization.(2013)。Adherence to longterm therapies: Evidence for action,http://www.who.int/hiv/pub/prev_care/lttherapies/en/index.html。 | |
| |